Effect of portal pressure gradient reduction on outcomes after transjugular intrahepatic portosystemic shunt in portal hypertension patients

Figure 3 Kaplan-Meier survival for six outcomes between group A (portal pressure gradient reduction ≤ 50%) and group B (portal pressure gradient reduction > 50%) before propensity score matching. A: Rebleeding-free survival (P = 0.002); B: Shunt dysfunction-free survival (P < 0.001); C: Hepatic encephalopathy-free survival (P < 0.001); D: Hepatocellular carcinoma-free survival (P = 0.003); E: Liver failure-free survival (P = 0.002); F: Overall survival (P = 0.003). HE: Hepatic encephalopathy.